Skip to content

The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps

The RELAX Trial: Nonpharmaceutical Intervention for Nocturnal Muscle Cramps

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05457322
Acronym
RELAX
Enrollment
99
Registered
2022-07-14
Start date
2022-08-30
Completion date
2023-08-14
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cramps, Muscle Cramp

Keywords

Nighttime muscle cramps, Cirrhosis, Liver disease, Qualify of life, Sleep, Non-Pharmaceutical intervention

Brief summary

The purpose of the study is to learn about reducing the symptoms and severity of nighttime lower body muscle cramps in patients with and without cirrhosis. Eligible participants will have an initial 7-day practice phase, followed by 28 days of one of two behavioral interventions.

Detailed description

The interventions in this trial can be done at home. Openly discussing the intervention groups with all participants prior to randomization thus poses a high risk of tainting the study because subjects in the one group may start doing the other groups exercises after having heard about it during the consent process as a way to potentially reduce the symptoms and severity of painful muscle cramps. Therefore, this study will conceal information regarding the nature of the interventions. Only participants randomized to the true intervention group will be told during the study period what the behavioral intervention is. Additionally, the title of this trial upon registration is listed slightly differently than it is listed with the Institutional Review Board (IRB), to provide scientific integrity with the masking requirements. When the trial is completed, the title will be amended to match the IRB approved title. At the conclusion of the study, at the time of the final follow-up assessments, all participants will be debriefed on the use of the concealment of the study object in this study.

Interventions

BEHAVIORALBehavioral intervention one

Participants will view or listen to audiovisual material and engage in a daily 10-minute exercise. Following the practice period participants will continue to do the true 28-day intervention period in which they were randomized to.

BEHAVIORALBehavioral intervention two

Participants will view or listen to audiovisual material and engage in a daily 10-minute exercise. Following the practice period participants will continue to do the true 28-day intervention period in which they were randomized to.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants have painful muscle spasms, cramps, or charley horses at night in feet or legs. * Participants have muscle cramps that happen at least four times in the past month. And the muscle cramps bother them. * For Cirrhosis patients only: diagnosis of cirrhosis based upon: 1. liver biopsy, or 2. history of cirrhosis complication: ascites, variceal bleeding, hepatic encephalopathy, or 3. 2 of the following 4 criteria: * Ultrasound (US), computerized tomography (CT) or Magnetic resonance imaging (MRI) imaging findings of cirrhosis (cirrhotic appearing liver, splenomegaly, varices, ascites) * FibroScan liver stiffness score \>13 kilopascal (kPa) * Laboratory testing: aspartate aminotransferase (AST)/platelet ratio index (APRI) \>2.0 * CT, MRI or esophagogastroduodenoscopy (EGD) showing presence of esophageal varices

Exclusion criteria

* Non-English speaking * Unable or unwilling to provide consent * Pregnancy via self-report * Disorientation at the time of enrollment * History of multiple sclerosis * History of cerebral palsy * History of stroke with paralysis

Design outcomes

Primary

MeasureTime frameDescription
Change in cramp severity after 35-days as measured by the Visual Analog Scale for Crampsbaseline, 35 daysThis is a one question scale from 0 to 10; 0 indicates no cramps and 10 indicates worst cramps imaginable.

Secondary

MeasureTime frameDescription
Patient global impression of change (PGIC)35 daysThis is a one question survey in which the participants rate overall status as one of the following: Very Much Improved, Much Improved, Minimally Improved, No Change, Minimally Worse, Much Worse, Very Much Worse. Comparison of PGIC scores at 35 days between both arms.
Change in sleep quality assessed by the Pittsburgh Sleep Quality Index (PSQI).baseline, 35 daysThis is a one question survey in which the participants rate overall sleep quality as one of the following: Very good, Good, Fair, Bad, Very bad.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026